Richwood Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Richwood Investment Advisors's BIIB Position: Q2 2026 in Review
Richwood Investment Advisors increased its Biogen (BIIB) stake by 12% in Q2 2026, buying an estimated $45K and bringing the position to 2,267 shares worth $490K. The position accounts for 0.34% of the portfolio, ranked #64.
Richwood Investment Advisors first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.33M in Q4 2022. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Richwood Investment Advisors held 2,267 shares of Biogen worth $490K as of Q2 2026.
- Richwood Investment Advisors bought 235 Biogen shares in Q2 2026, an estimated $45K.
- Biogen made up 0.34% of Richwood Investment Advisors's portfolio in Q2 2026, its #64 holding.
- Richwood Investment Advisors first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- Richwood Investment Advisors's Biogen position peaked at $1.33M in Q4 2022.
- 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.